
Dear Research Advocate: I moderated a session at the always-compelling Aspen Institute’s Spotlight Health conference at the end of last week. We had a robust and “un-sugarcoated” discussion on the dual imperatives of affordability and fast-paced medical progress. Among the many terrific conference sessions were two featuring the newly announced CEO of the Amazon-Berkshire Hathaway-Morgan Stanley initiative, Dr. Atul Gawande. (I should add that he mentioned that they will arrive at a better name!) During his interview with PBS NewsHour’s Judy Woodruff, Dr. Gawande, whom I am proud to say was our Isadore Rosenfeld Advocacy Awardee this past March, made the point that not being thoughtful...